Neurosense Therapeutics Ltd (NRSN) Live Share Price, Invest From India

Neurosense Therapeutics Ltd Stock Performance

as on May 19, 2026 at 5:39 am IST

Day's Low
Day's High
$0.74
Day's Price Range
$0.87
$0.76
2.63%
Downside
14.47%
Upside
52 Week's Low
52 Week's High
$0.63
52-Week Price Range
$2.60
$0.76
17.11%
Downside
242.11%
Upside

Neurosense Therapeutics Ltd share price movements today

Previous Close: $0.83
Open: $0.84
Volume: 3.3M
Day's Low - High: $0.74 - $0.87
52 Week Low - High: $0.63 - $2.60

Neurosense Therapeutics Ltd Historical Returns

1 Month Return: + 16.92 %
3 Month Return: -3.11 %
1 Year Return: -37.38 %
3 Year Return: -51.66 %
5 Year Return: 0 %

Neurosense Therapeutics Ltd Stock Fundamentals & Key Indicators

Check Neurosense Therapeutics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$30.1M

EPS (TTM)

-0.305

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-11.1M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-2174.98%

Neurosense Therapeutics Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Neurosense Therapeutics Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Neurosense Therapeutics Ltd	BUY	$30.1M	NA	NA	0.00%
Revolution Medicines Inc	BUY	$31.8B	341.26%	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.2B	112.34%	73.55	12.55%
Vertex Pharmaceuticals Inc	BUY	$115.0B	103.57%	26.89	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.7B	35.26%	17.39	29.65%

Stock Returns calculator for Neurosense Therapeutics Ltd Stock including INR - Dollar returns

The Neurosense Therapeutics Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Neurosense Therapeutics Ltd investment value today

Current value as on today

₹64,956

Returns

-₹35,044

(-35.04%)

Returns from Neurosense Therapeutics Ltd Stock

-₹42,424 (-42.42%)

Dollar Impact

₹7,380 (+7.38%)

Analyst Recommendation on Neurosense Therapeutics Ltd Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Neurosense Therapeutics Ltd. Average target price of $8.38

Neurosense Therapeutics Ltd Share Price Target

Get share price movements and forecasts by analysts on Neurosense Therapeutics Ltd.

What analysts predicted

90.93%UPSIDE

Target Price

$8.38

Current Price

$0.76

Analyzed by

8 Analysts

Target

$8.38

Neurosense Therapeutics Ltd target price $8.38, a slight upside of 90.93% compared to current price of $0.76. According to 8 analysts rating.

Indian Investors' Interest in Neurosense Therapeutics Ltd Stock

Search interest for Neurosense Therapeutics Ltd Stock has decreased by -48% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 19, 2026 to May 19, 2026

Change:-48% versus previous 30 day period

Neurosense Therapeutics Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-
Operating Income	-2	-3	-2	-3	-2	-3	-2	-1
EBITDA	-2	-5	2	-	-2	-3	-2	-
Interest Expense	0	0	0	2	2	2	0	-
Depreciation	-	-	-	-	-	-	-	-
Income Before Tax	-2	-5	0	-2	-5	0	-2	-1
Income Tax Expense	0	-2	5	-	0	-	-	-
Net Income	-2	-5	0	-2	-5	0	-2	-1
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Neurosense Therapeutics Ltd Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-	0	0	0	0	0	-
Operating Income	-1	-2	-5	-13	-12	-9	-11
EBITDA	-1	-2	-2	-12	-9	-9	-11
Interest Expense	0	0	1	0	0	0	-
Depreciation	-	0	0	0	0	0	0
Income Before Tax	-1	-2	-4	-12	-10	-10	-11
Income Tax Expense	0	0	-1	-1	0	-	-
Net Income	-1	-2	-4	-12	-10	-10	-11
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Neurosense Therapeutics Ltd Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Net Income	0	0	-2	0	0	0	-1	0
Operating Cash Flow	0	-	-	-	-	-	-	0
Investing Cash Flow	-	-	-	-	-	-	-	0
Financing Cash Flow	-	-	-	-	-	-	-	0
Change in Cash	5	-2	-	-2	-	-	-	-

Neurosense Therapeutics Ltd Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-2	-4	-12	-10	-10	-11
Operating Cash Flow	0	-1	-7	-8	-10	-7
Investing Cash Flow	0	0	-3	3	0	0
Financing Cash Flow	0	11	3	3	10	4
Change in Cash	0	10	-7	0	0	-3

Global Institutional Holdings in Neurosense Therapeutics Ltd

Funds	Holdings
Two Sigma Investments LLC	0.15%
UBS Group AG	0.04%
Jane Street Group LLC	0%
Commonwealth Equity Services Inc	0.06%
Creative Planning Inc	0.03%

See all

Insights on Neurosense Therapeutics Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, NRSN stock has moved up by 16.9%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 473.9% return, outperforming this stock by 525.6%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 268.4% return, outperforming this stock by 305.8%

About Neurosense Therapeutics Ltd

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer's, as well as under preclinical studies for the treatment of Parkinson's disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. NeuroSense Therapeutics Ltd. was incorporated in 2017 and is headquartered in Herzliya, Israel.

Organisation	Neurosense Therapeutics Ltd
Headquarters	Building B, Herzliya, Israel, 4672562
Industry	Biotechnology
CEO	Mr. Alon Ben-Noon
E-voting on shares	Click here to vote

Key Management of Neurosense Therapeutics Ltd

Name	Title
Ms. Keren Pushett	Head of HR
Mr. Alon Ben-Noon	Co-Founder, CEO & Director
Mr. Or Eisenberg	Chief Financial Officer
Dr. Niva Russek-Blum Ph.D.	Chief Technology Officer
Ms. Yael Barak	VP of Quality & Compliance

FAQs

What is Neurosense Therapeutics Ltd share price today?

Neurosense Therapeutics Ltd share price today is $0.76 as on May 19, 2026 at 12:09 am IST. Neurosense Therapeutics Ltd share today touched a day high of $0.87 and a low of $0.74.

What is the 52 week high and 52 week low for Neurosense Therapeutics Ltd share?

Neurosense Therapeutics Ltd share touched a 52 week high of $2.6 on June 12, 2025 and a 52 week low of $0.63 on March 24, 2026. Neurosense Therapeutics Ltd stock price today i.e. May 19, 2026 at 12:09 am IST is trending at $0.76,which is 70.77% down from its 52 week high and 20.63% up from its 52 week low.

What is Neurosense Therapeutics Ltd's market capitalisation today?

Neurosense Therapeutics Ltd market capitalisation is $0.00T as on May 19, 2026 at 12:09 am IST.

How to invest in Neurosense Therapeutics Ltd Stock (NRSN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Neurosense Therapeutics Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neurosense Therapeutics Ltd Shares that will get you 1.9737 shares as per Neurosense Therapeutics Ltd share price of $0.76 per share as on May 19, 2026 at 12:09 am IST.

What is the minimum amount required to buy Neurosense Therapeutics Ltd Stock (NRSN) from India?

Indian investors can start investing in Neurosense Therapeutics Ltd (NRSN) shares with as little as ₹96.335 or $1 (as of May 19, 2026 at 12:10 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹963.35 in Neurosense Therapeutics Ltd stock (as per the Rupee-Dollar exchange rate as on May 19, 2026 at 12:10 am IST). Based on Neurosense Therapeutics Ltd share’s latest price of $0.76 as on May 19, 2026 at 12:09 am IST, you will get 13.1579 shares of Neurosense Therapeutics Ltd. Learn more about fractional shares .